Literature DB >> 15645377

Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.

K J Sørensen1, K de Stricker, K C Dyrting, S Grazioli, B Haas.   

Abstract

A blocking ELISA that differentiated foot-and-mouth disease virus (FMDV) infected animals from vaccinated animals was developed which uses baculovirus expressed FMDV 3ABC non-structural protein as antigen and monoclonal antibody against FMDV 3ABC non-structural protein as capture and detector antibody. Sera from naive, vaccinated and infected cattle, sheep and pigs were examined. The specificity of the test was high. Non-specific reactions observed in particular in sera of cattle and sheep could be removed by filtration and inactivation. Positive reactions were obtained for sera from cattle infected with all seven serotypes of FMDV. The test detected antibodies from days 7 or 9 following experimental infection of non-vaccinated cattle and sheep, and in cattle strong positive reactions persisted for up to 395 days after infection. In vaccinated cattle that became carriers after challenge with homologous FMDV, positive reactions were obtained in all but one case. In some of these cattle the antibody response was detected late in comparison to the non-vaccinated infected cattle. The test gave results that compared favourably with two commercial ELISA's when used to test sera from cattle, pigs and sheep collected after experimental or natural infection. The blocking ELISA based on recombinant FMDV 3ABC antigen and a monoclonal antibody to 3ABC is a promising tool for FMD control and eradication campaigns, where vaccination has been carried out.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645377     DOI: 10.1007/s00705-004-0455-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

Review 1.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

2.  Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Authors:  Jun-Jun Shao; Chung Kai Wong; Tong Lin; Shuk Kwan Lee; Guo-Zheng Cong; Fion Wai Yee Sin; Jun-Zheng Du; Shan-Dian Gao; Xiang-Tao Liu; Xue-Peng Cai; Yong Xie; Hui-Yun Chang; Ji-Xing Liu
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

3.  A new blocking ELISA for detection of foot-and-mouth disease non-structural protein (NSP) antibodies in a broad host range.

Authors:  Madhusudan Hosamani; Shreya Gopinath; B P Sreenivasa; Subhasmita Behera; Suresh H Basagoudanavar; Ashok Boora; Durlav P Bora; Pankaj Deka; Veerakyathappa Bhanuprakash; Raj Kumar Singh; Aniket Sanyal; Klaas Weerdmeester; Aldo Dekker
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-12       Impact factor: 5.560

4.  Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.

Authors:  Mauro Pires Moraes; Teresa de Los Santos; Marla Koster; Traci Turecek; He Wang; Vladimir G Andreyev; Marvin J Grubman
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

5.  Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease.

Authors:  Julie Perkins; Satya Parida; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

6.  Redefining the "carrier" state for foot-and-mouth disease from the dynamics of virus persistence in endemically affected cattle populations.

Authors:  Barend M deC Bronsvoort; Ian G Handel; Charles K Nfon; Karl-Johan Sørensen; Viviana Malirat; Ingrid Bergmann; Vincent N Tanya; Kenton L Morgan
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

7.  Discriminating foot-and-mouth disease virus-infected and vaccinated animals by use of beta-galactosidase allosteric biosensors.

Authors:  M Teresa Sánchez-Aparicio; María Flora Rosas; Rosa Maria Ferraz; Laura Delgui; Juan J Veloso; Esther Blanco; Antonio Villaverde; Francisco Sobrino
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

8.  Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus.

Authors:  Ming Yang; Satya Parida; Tim Salo; Kate Hole; Lauro Velazquez-Salinas; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

9.  The role of African buffalos (Syncerus caffer) in the maintenance of foot-and-mouth disease in Uganda.

Authors:  Chrisostom Ayebazibwe; Frank N Mwiine; Kirsten Tjørnehøj; Sheila N Balinda; Vincent B Muwanika; Anna R Ademun Okurut; Graham J Belsham; Preben Normann; Hans R Siegismund; Soren Alexandersen
Journal:  BMC Vet Res       Date:  2010-12-11       Impact factor: 2.741

10.  Evaluation of three 3ABC ELISAs for foot-and-mouth disease non-structural antibodies using latent class analysis.

Authors:  Barend M deC Bronsvoort; Nils Toft; Ingrid E Bergmann; Karl-Johan Sørensen; John Anderson; Viviane Malirat; Vincent N Tanya; Kenton L Morgan
Journal:  BMC Vet Res       Date:  2006-10-16       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.